Navigation Links
Pearl Therapeutics' Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
Date:5/18/2011

or many patients.  I am especially optimistic that PT003 has the potential of fulfilling this unmet need for COPD patients at all stages of severity."

Expanding the benefits beyond its primary endpoint, PT003 also demonstrated a statistically significant improvement in peak FEV1 on day one, with further benefit observed on day seven relative to all comparators and placebo. Treatment with PT003 yielded an improvement in peak FEV1 levels of 42% (or 64 mL) over Foradil and 74% (or 92 mL) over Spiriva as measured on day one; and an improvement of 37% (or 89 mL) over Foradil and 75% (or 141 mL) over Spiriva when measured on day seven (p<0.03 for all comparisons). Furthermore, PT003 demonstrated a faster onset of action than did Spiriva on day one (75% higher probability of onset at any time point during the first 2 hours following administration, p</=0.0003).

PT003 also demonstrated a significant improvement in morning trough FEV1, which is a measure of lung function in patients before they receive their first dose of medication in the morning. This is a particularly relevant measurement for COPD patients who often report that their symptoms are most severe in the morning and cause them to struggle with morning activities. In this Phase 2b study, following one week of study medication, morning trough FEV1 levels in the PT003 arm were improved by 48% (or 68 mL) over Foradil and 52% (or 73 mL) over Spiriva (p<0.014 for both measures).

"The overall improvement in lung function, including the fast onset of action with higher peak improvements in FEV1 and morning trough FEV1 is a strong indicator of how PT003's twice-a-day dosing can benefit patients' disease management," continued Dr. Reisner. "To assess the full clinical potential of PT003, and ensure that we have the strongest possible regulatory package, we plan to initiate four additional Phase 2b studies in the next few weeks. These studies will further
'/>"/>

SOURCE Pearl Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
2. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
3. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
4. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
5. Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics
6. Regency Therapeutics and Daiichi Sankyo Announce Launch and Commercial Availability of SPRIX® (ketorolac tromethamine) Nasal Spray
7. Inhibikase Therapeutics Elects Steven C. Gilman, Ph.D., to Board of Directors
8. Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer
9. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
10. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
11. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)...  In anticipation of the upcoming MEDevice San Diego ... the first time. Industry Overview: Medtech & Life Sciences ... snapshot of San Diego,s critical involvement ... latest employment statistics to current venture capital investment trends, the ... such a vital part of the global medical device ...
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate ... The Gambia and Mali ... safety trials of potential vaccines aimed at preventing the disease that ... West Africa . Human trials of ... Health (NIH) and GlaxoSmithKline, are to be accelerated with funding from ...
(Date:8/28/2014)... 2014 According to a new ... (RFID) Market (Tags, Readers, Middleware, Printers and Cabinets) - ... 2014 - 2020" the global radiofrequency identification (RFID) market ... is expected to grow at a CAGR of 13.9% ... of USD 5.3 billion in 2020. Browse ...
Breaking Medicine Technology:New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5
... Md., Sept. 15 Pre-mixed insulin,analogues, a modified ... than long-acting analogues for controlling high blood sugar,levels ... according to a report,funded by the Agency for ... of Health and Human Services., Conventional pre-mixed ...
... Results inconclusive, as primary outcome measure not statistically ... by improvement in placebo group, ... -- Overall safety and tolerability profile comparable to placebo, ... -- Next steps include further analysis of full dataset ...
Cached Medicine Technology:Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 2AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 3AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease 4
(Date:8/29/2014)... New York (PRWEB) August 29, 2014 ... of Micro-Needling services in their Latham aesthetic office. ... technology, is one of the first surgeons in the ... . The innovative technique is faster and safer ... , Micro-Needling is a noninvasive procedure , ...
(Date:8/29/2014)... Aug. 29, 2014 (HealthDay News) -- Researchers have discovered ... their brains. Dyslexia -- the most commonly diagnosed ... with reading and writing. Previous research showed that ... most of those studies focused only on a small ... functional MRI to analyze how multiple brain regions use ...
(Date:8/29/2014)... August 29, 2014 Parker Waichman LLP, ... to protecting the rights of victims who have been ... (DEA) has announced new regulations for all hydrocodone combination ... (RAPS) report dated August 21, 2014, the DEA ... drugs under federal law. , The long-awaited announcement ...
(Date:8/29/2014)... Hastings and Hastings, a Phoenix personal injury ... many years is pleased to report having saved a ... convenient locations throughout the Valley, Hastings and Hastings offers ... attorney. In addition, experienced personal injury lawyers can arrange ... dedication and service is indicative of a law firm ...
(Date:8/29/2014)... August 29, 2014 Many Americans are ... keep diabetes type 2 at bay, patients should consider ... make the necessary lifestyle changes. While some diabetes risk ... history, advanced age, or belonging to certain ethnic groups, ... – their weight. Carrying extra pounds, especially in the ...
Breaking Medicine News(10 mins):Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $20,900 On A Settlement Of $190,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $20,900 On A Settlement Of $190,000 3Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 3
... Reinberg HealthDay Reporter , TUESDAY, Oct. 5 ... scans for injury-related emergency room visits in the United ... "There has been a dramatic increase in the likelihood ... to emergency departments for injury-related conditions without a corresponding ...
... DATE: Dana-Farber/Children,s Hospital Cancer Care is hosting the 42nd Congress ... pediatric oncology meeting in the world, SIOP is returning to ... Dates:, Thursday, Oct. 21, through Sunday, Oct. 24, ... p.m., Thursday through Saturday, and 8 a.m. to 3 p.m. ...
... Serena Gordon HealthDay Reporter , TUESDAY, Oct. 5 ... they not only protect themselves throughout their pregnancy but may ... few months of life. A study published online ... Medicine found that when women were vaccinated in the ...
... GRAND RAPIDS, MICH., Oct. 5, 2010 Only about ... and vegetable intake recommendations, which means they are ... health benefits (1). Along with vitamins, minerals and fiber, ... carotenoids, which research suggests help support women,s health including ...
... , TUESDAY, Oct. 5 (HealthDay News) -- Sophisticated brain ... patients with mild cognitive impairment are likely to progress ... combination of specialized MRI scans and an artificial intelligence ... were able to predict which patients had mild cognitive ...
... the microscope in a major new study, led by an ... its potential advantages and disadvantages. The study, which is ... examine the motives people have for travelling across national boundaries ... hip or joint replacement, cosmetic surgery and fertility treatment. ...
Cached Medicine News:Health News:MRI, CT Scans for ER Patients Triple Over Decade 2Health News:MRI, CT Scans for ER Patients Triple Over Decade 3Health News:Boston, Oct. 21-24: Largest international pediatric oncology conference 2Health News:Mom's Flu Shot May Protect Baby After Birth 2Health News:Mom's Flu Shot May Protect Baby After Birth 3Health News:Shortfalls in carotenoid intake may impact women's health 2Health News:Shortfalls in carotenoid intake may impact women's health 3Health News:Shortfalls in carotenoid intake may impact women's health 4Health News:Computer-Aided MRI Might Help Predict Alzheimer's 2Health News:Computer-Aided MRI Might Help Predict Alzheimer's 3Health News:Traveling for treatment: The case for and against 2
The Perfecta IMC Stems, manufactured from forged cobalt- chrome, are specifically designed for cemented femoral stem arthroplasty....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Simple straight stem design for the low-demand patient....
Dual offset femoral stems, hip stems that provide unique and competitive features....
Medicine Products: